NervGen Pharma Corp. (NGEN) — Strategic Asset Allocation Index
NervGen Pharma Corp. (NGEN) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $3.48 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check NervGen Pharma Corp. (NGEN) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
NervGen Pharma Corp. Strategic Asset Allocation Index (2024–2025)
This chart shows how NervGen Pharma Corp.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $3.48 Million USD. See NervGen Pharma Corp. (NGEN) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for NervGen Pharma Corp. (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for NervGen Pharma Corp. from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NervGen Pharma Corp. market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $3.48 Million | ▼ -0.3 pp |
| 2024 | 0.3% | $8.37K | $- | $8.37K | $2.57 Million | — |